Skip to Main Content

Paper Details

The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.
Semin Arthritis Rheum
3
2020
CYC, ILD, MMF, MUC5B minor allele, MUC5B promoter, MUC5B promoter variant, MUC5B rs35705950, MUC5B variant, Patients, SSc, SSc-ILD, Scleroderma, allele, cyclophosphamide, fibrosis, interstitial lung disease, mycophenolate, participants, patients, rs35705950, single nucleotide polymorphism, systemic sclerosis
Author NameAffiliation
Maureen D MayesMcGovern Medical School at the University of Texas Health Science Center at Houston
Grace Hyun J KimUniversity of California, David Geffen School of Medicine, Fielding School of Public Health Los Angeles
Jonathan G GoldinUniversity of California, David Geffen School of Medicine los angeles
Jonathan G GoldinUniversity of California, David Geffen School of Medicine los angeles
  • 1 - 4

Datasets

Release 1.2